Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28400901 | 0.98 | TSHR (0.43) | TSHRHPGDALDH1A1TP53HIF1A | |
| Sulfuric Acid SCHEMBL128048 | 0.91 | TSHR (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| Sulfuric Acid SCHEMBL27667403 | 0.91 | TSHR (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| Sulfuric Acid Dimethyl Ester SCHEMBL2527183 | 0.90 | TSHR (0.44) | TSHRHPGDALDH1A1TP53HIF1A | |
| Sulfuric Acid SCHEMBL28351009 | 0.90 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| Sulfuric Acid SCHEMBL28251440 | 0.90 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL17003984 | 0.90 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL28515730 | 0.88 | TSHR (0.50) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL15115 | 0.88 | TSHR (0.56) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL28802094 | 0.87 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070397-A | Use of fast reverse cationic emulsion polymers with polyvinylamines as retention and drainage aids | 凯米拉公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4739418-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2026-05-13 | — | — | EP | claimed |
| EP-4728136-A1 | STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID | Ecolab USA, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4716777-A2 | USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2026-04-01 | — | — | EP | claimed |
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | claimed |
| EP-4683950-A1 | DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY | KEMIRA OYJ (FI) | 2026-01-28 | — | — | EP | claimed |
| US-20250215649-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | KEMIRA OYJ (FI) | 2025-07-03 | — | — | US | claimed |
| US-20250137200-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | KEMIRA OYJ (FI) | 2025-05-01 | — | — | US | claimed |
| EP-4256009-B1 | OIL-IN-WATER EMULSIONS | QUADRISE INT LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| WO-2025072390-A1 | USE OF QUICK INVERSION CATIONIC EMULSION POLYMERS WITH POLYVINYLAMINES AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2025-04-03 | — | — | WO | claimed |
| US-20020198317-A1 | Preparation of water soulble polymer dispersions from vinylamide monomers | ECOLAB USA INC. | 2002-12-26 | — | — | US | claimed |
| US-6344531-B1 | Fluorescent water-soluble polymers | NALCO CHEMICAL COMPANY | 2002-02-05 | — | — | US | claimed |
| WO-2001081654-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO COMPANY (US) | 2001-11-01 | — | — | WO | claimed |
| US-6177017-B1 | COMPLEXING WITH 1,4-DIAZABICYCLO(2.2.2) OCTANE POLYMERS | NALCO CHEMICAL COMPANY | 2001-01-23 | — | — | US | claimed |
| US-6114484-A | REMOVAL OF METAL CYANIDES OR OXOANIONS FROM AQUEOUS STREAMS SUCH AS WASTE WATER STREAMS WITH COMPOUNDS CONTAINING 1,4-DIAZABICYCLO(2.2.2)OCTANE | NALCO CHEMICAL COMPANY (US) | 2000-09-05 | — | — | US | claimed |
| EP-0984990-A1 | PREPARATION OF WATER SOLUBLE POLYMER DISPERSIONS FROM VINYLAMIDE MONOMERS | NALCO CHEMICAL COMPANY (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0970258-A1 | POLYMERIC COMBINATIONS USED AS COPPER AND PRECIOUS METAL HEAP LEACHING AGGLOMERATION AIDS | NALCO CHEMICAL COMPANY (US) | 2000-01-12 | — | — | EP | claimed |
| WO-1999020803-A1 | POLYMERIC COMBINATIONS USED AS COPPER AND PRECIOUS METAL HEAP LEACHING AGGLOMERATION AIDS | NALCO CHEMICAL COMPANY (US) | 1999-04-29 | — | — | WO | claimed |
| WO-1998054234-A1 | PREPARATION OF WATER SOLUBLE POLYMER DISPERSIONS FROM VINYLAMIDE MONOMERS | NALCO CHEMICAL COMPANY (US) | 1998-12-03 | — | — | WO | claimed |
| US-5833937-A | AGGLOMERATING BY SEQUENTIAL ADDITION OF FIRST WATER SOLUBLE ANIONIC OR NONIONIC POLYMER AND SECOND CATIONIC WATER SOLUBLE POLYMER | NALCO CHEMICAL COMPANY (US) | 1998-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | CHRM1 848/4885CHRM3 1722/4885TSHR 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.